Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares IssuedShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biote (BTMD) Change in Accured Expenses (2021 - 2025)

Biote has reported Change in Accured Expenses over the past 5 years, most recently at -$1.3 million for Q4 2025.

  • Quarterly results put Change in Accured Expenses at -$1.3 million for Q4 2025, down 127.6% from a year ago — trailing twelve months through Dec 2025 was -$2.7 million (down 159.22% YoY), and the annual figure for FY2025 was -$2.7 million, down 159.22%.
  • Change in Accured Expenses for Q4 2025 was -$1.3 million at Biote, down from $2.4 million in the prior quarter.
  • Over the last five years, Change in Accured Expenses for BTMD hit a ceiling of $4.9 million in Q3 2023 and a floor of -$26.1 million in Q2 2022.
  • Median Change in Accured Expenses over the past 5 years was -$205000.0 (2021), compared with a mean of -$1.1 million.
  • Biggest five-year swings in Change in Accured Expenses: crashed 32986.68% in 2022 and later surged 358.59% in 2024.
  • Biote's Change in Accured Expenses stood at $2.7 million in 2021, then plummeted by 79.64% to $555000.0 in 2022, then tumbled by 421.08% to -$1.8 million in 2023, then surged by 358.59% to $4.6 million in 2024, then plummeted by 127.6% to -$1.3 million in 2025.
  • The last three reported values for Change in Accured Expenses were -$1.3 million (Q4 2025), $2.4 million (Q3 2025), and -$1.2 million (Q2 2025) per Business Quant data.